Andreas Papapetropoulos
Overview
Explore the profile of Andreas Papapetropoulos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
158
Citations
5423
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zuhra K, Petrosino M, Janickova L, Petric J, Ascencao K, Vignane T, et al.
Nat Metab
. 2025 Mar;
PMID: 40033006
Small, gaseous molecules such as nitric oxide, carbon monoxide and hydrogen sulfide are produced as signalling molecules in mammalian cells. Here, we show that low concentrations of cyanide are generated...
2.
Topouzis S, Papapetropoulos A, Alexander S, Cortese-Krott M, Kendall D, Martemyanov K, et al.
Br J Pharmacol
. 2025 Feb;
182(7):1416-1445.
PMID: 39971274
In the past year, the European Medicines Agency (EMA), the Food and Drug Administration (FDA) and the Medicines and Healthcare Products Regulatory Agency (MHRA) authorised 53 novel drugs. While the...
3.
Curtis M, Alexander S, Cortese-Krott M, Kendall D, Martemyanov K, Mauro C, et al.
Br J Pharmacol
. 2025 Jan;
182(7):1413-1415.
PMID: 39865712
No abstract available.
4.
Li Z, LaPenna K, Gehred N, Yu X, Tang W, Doiron J, et al.
bioRxiv
. 2025 Jan;
PMID: 39763741
Background: Recent reports suggest increased myocardial iNOS expression leads to excessive protein -nitrosylation, contributing to the pathophysiology of HFpEF. However, the relationship between NO bioavailability, dynamic regulation of protein -nitrosylation...
5.
Zampas P, Li Z, Katsouda A, Varela A, Psarras S, Davos C, et al.
Pharmacol Res
. 2024 Dec;
211():107542.
PMID: 39667544
Metabolic syndrome (MetS) is a cluster of metabolic abnormalities that occur concurrently and increase the risk of cardiovascular disease. 3-mercaptopyruvate sulfurtransferase (MPST) is a cysteine-catabolizing enzyme that yields pyruvate and...
6.
Wang X, Izzo A, Papapetropoulos A, Alexander S, Cortese-Krott M, Kendall D, et al.
Br J Pharmacol
. 2024 Aug;
181(19):3547-3555.
PMID: 39128855
Natural products (NPs) have long been used as a rich source of bioactive compounds for drug development. Recent technological advancements have revitalised natural products research as evidenced by increased publications...
7.
Markou M, Katsouda A, Papaioannou V, Argyropoulou A, Vanioti M, Tamvakopoulos C, et al.
Phytother Res
. 2024 Aug;
38(9):4757-4773.
PMID: 39120436
Obesity is a major source of morbidity worldwide with more than 2 billion adults being overweight or obese. The incidence of obesity has tripled in the last 50 years, leading...
8.
Papapetropoulos A, Topouzis S, Alexander S, Cortese-Krott M, Kendall D, Martemyanov K, et al.
Br J Pharmacol
. 2024 Mar;
181(11):1553-1575.
PMID: 38519837
In 2023, seventy novel drugs received market authorization for the first time in either Europe (by the EMA and the MHRA) or in the United States (by the FDA). Confirming...
9.
Drekolia M, Karantanou C, Wittig I, Li Y, Fuhrmann D, Brune B, et al.
Redox Biol
. 2024 Jan;
69:103014.
PMID: 38171255
Protein persulfidation is a significant post-translational modification that involves addition of a sulfur atom to the cysteine thiol group and is facilitated by sulfide species. Persulfidation targets reactive cysteine residues...
10.
Alexander S, Fabbro D, Kelly E, Mathie A, Peters J, Veale E, et al.
Br J Pharmacol
. 2023 Dec;
180 Suppl 2:S289-S373.
PMID: 38123154
The Concise Guide to PHARMACOLOGY 2023/24 is the sixth in this series of biennial publications. The Concise Guide provides concise overviews, mostly in tabular format, of the key properties of...